Xenon is an Inhibitor of Tissue-Plasminogen Activator: Adverse and Beneficial Effects in a Rat Model of Thromboembolic Stroke
Open Access
- 20 January 2010
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 30 (4) , 718-728
Abstract
Preclinical evidence in rodents has proven that xenon may be a very promising neuroprotective agent for treating acute ischemic stroke. This has led to the general thinking that clinical trials with xenon could be initiated in acute stroke patients in a next future. However, an unappreciated physicochemical property of xenon has been that this gas also binds to the active site of a series of serine proteases. Because the active site of serine proteases is structurally conserved, we have hypothesized and investigated whether xenon may alter the catalytic efficiency of tissue-type plasminogen activator (tPA), a serine protease that is the only approved therapy for acute ischemic stroke today. Here, using molecular modeling and in vitro and in vivo studies, we show (1) xenon is a tPA inhibitor; (2) intraischemic xenon dose dependently inhibits tPA-induced thrombolysis and subsequent reduction of ischemic brain damage; (3) postischemic xenon virtually suppresses ischemic brain damage and tPA-induced brain hemorrhages and disruption of the blood–brain barrier. Taken together, these data indicate (1) xenon should not be administered before or together with tPA therapy; (2) xenon could be a golden standard for treating acute ischemic stroke if given after tPA-induced reperfusion, with both unique neuroprotective and antiproteolytic (anti-hemorrhaging) properties.Keywords
This publication has 50 references indexed in Scilit:
- Human Recombinant Tissue-Plasminogen Activator (Alteplase): Why Not Use the ‘Human’ Dose for Stroke Studies in Rats?Journal of Cerebral Blood Flow & Metabolism, 2010
- Neuronal Preconditioning by Inhalational AnestheticsAnesthesiology, 2009
- Xenon Preconditioning Protects against Renal Ischemic-Reperfusion Injury via HIF-1α ActivationJournal of the American Society of Nephrology, 2009
- Xenon induces transcription of ADNP in neonatal rat brainNeuroscience Letters, 2008
- Speed of tPA-Induced Clot Lysis Predicts DWI Lesion Evolution in Acute StrokeStroke, 2007
- Protein Crystallography under Xenon and Nitrous Oxide Pressure: Comparison with In Vivo Pharmacology Studies and Implications for the Mechanism of Inhaled Anesthetic ActionBiophysical Journal, 2007
- Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic StrokeStroke, 2005
- Exciting, Radical, SuicidalStroke, 2005
- Selfotel in Acute Ischemic StrokeStroke, 2000
- Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic StrokeStroke, 1997